Zhaoyi Liu

机构：Central South University, Beijing University of Chinese Medicine, Tianjin Medical University General Hospital, Tianjin Medical University Cancer Institute and Hospital, Ministry of Education, Hunan Cancer Hospital, Shenzhen Bao'an District People's Hospital, Chongqing Public Health Medical Center, Chongqing Medical University · ORCID：0000-0001-8563-7665

发表论文 53 篇 · 总被引 1229 次 · h-index 13

代表论文

• A Pyroptosis-Related LncRNA Signature for Predicting Prognosis, Immune Features and Drug Sensitivity in Ovarian Cancer (2025 · OncoTargets and Therapy · 被引 19)
• Identification of the tumor metastasis-related tumor subgroups overexpressed NENF in triple-negative breast cancer by single-cell transcriptomics (2024 · Cancer Cell International · 被引 19)
• Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology (2023 · Journal of Cancer Research and Clinical Oncology · 被引 18)
• Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China (2024 · Cancer Immunology Immunotherapy · 被引 16)
• Integrating multi-omics data reveals the antitumor role and clinical benefits of gamma-delta T cells in triple-negative breast cancer (2025 · BMC Cancer · 被引 13)
• First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (2024 · Med · 被引 9)